FindTrial
Sign In

Intracameral anaesthetic mydriatic versus topical mydriasis in Pediatric Cataract Surgery

Intracameral anaesthetic mydriatic versus topical mydriasis in Pediatric Cataract Surgery: a randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/04/033232
Enrollment
57
Registered
2021-04-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H260- Infantile and juvenile cataract

Interventions

Intervention1: intracameral anesthetic mydriatic combination: All children would undergo routine preoperative assessment as already being followed for a case of cataract. Eligible patients will be ran

Sponsors

NO SPONSOR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients(0-12 years) with bilateral cataract scheduled for surgery will be enrolled

Exclusion criteria

Exclusion criteria: Hypersensitivity to the active substances (Tropicamide, Phenylephrine Hydrochloride and Lidocaine Hydrochloride) , glaucoma and patients with synechiae or any other pupillary abnormalities.

Design outcomes

Primary

MeasureTime frame
To evaluate the safety and efficacy of intracameral mydriatic anaesthetic combination of phenylephrine (0.31%), tropicamide (0.02%) and lidocaine (1%) (Phenocaine Plus 1ml,Entod pharma, Gujarat, India) compared to topical mydriasis (tropicamide 0.8%, Phenylephrine 5% and cyclopentolate 0.5%) on pupillary expansion in pediatric cataract surgery.Timepoint: one day and one week—

Secondary

MeasureTime frame
cost analysisTimepoint: one day—

Countries

India

Contacts

Public ContactJASPREET SUKHIJA

Post Graduate Institute of Medical Education and Research,Chandigarh,India

jaspreetsukhija@yahoo.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026